title: NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
abstract: Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate autoimmune diseases. However, their role in the pathogenesis of systemic lupus erythematosus (SLE) has not been extensively studied. The aim of this study was to analyse the immunophenotypic and functional characteristics of the two major NK cell subsets in SLE and relate them with disease activity. Peripheral blood samples from 44 patients with active (n = 18) and inactive SLE (n = 26) and 30 controls were analysed by flow cytometry to evaluate NK cell subsets, according to: the differential expression of CXCR3 and CD57; expression of granzyme B and perforin; and production of interferon gamma (IFN-γ) and tumor necrosis alpha (TNF-α), after PMA/ionomycin activation. A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected. Active SLE was associated with a reduced CXCR3 expression on both NK cell subsets and a lower frequency of CD56(dim) NK cells expressing CXCR3. Furthermore, granzyme B expression was decreased in both SLE groups, but the percentage of NK cells expressing granzyme B and perforin was higher, particularly in active disease. We found a significant decrease in the percentage of CD56(bright) and CD56(dim) NK cells producing TNF-α and of its expression on CD56(dim) NK cells in active disease, while IFN-γ expression on CD56(bright) NK cells was increased in both SLE groups. Our findings suggest that NK cell subsets exhibit unique phenotypic and functional changes that are particularly evident in active SLE, and they may have the potential to affect the disease outcome.
authors: Centro do Sangue e da Transplantação de Coimbra | Instituto Português do Sangue e da Transplantação, Edifício São Jerónimo. 4 Piso, Praceta Mota Pinto, 3001-301 Coimbra, Portugal.
authors: Ana
authors: A
authors: Henriques
authors: Luís
authors: L
authors: Teixeira
authors: Luís
authors: L
authors: Inês
authors: Tiago
authors: T
authors: Carvalheiro
authors: Ana
authors: A
authors: Gonçalves
authors: António
authors: A
authors: Martinho
authors: Maria Luísa
authors: ML
authors: Pais
authors: José António Pereira
authors: JA
authors: da Silva
authors: Artur
authors: A
authors: Paiva
mesh_terms: D000328:Adult; D019002:CD56 Antigen / Q000378:metabolism; D018959:CD57 Antigens / Q000378:metabolism; D016022:Case-Control Studies; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry; D053804:Granzymes / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D015759:Ionomycin / Q000737:chemistry; D007694:Killer Cells, Natural / Q000378:metabolism / Q000473:pathology*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D054353:Perforin / Q000378:metabolism; D054367:Receptors, CXCR3 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D055815:Young Adult
chemical_list: D019002:CD56 Antigen; D018959:CD57 Antigens; C515187:CXCR3 protein, human; D016207:Cytokines; D054367:Receptors, CXCR3; D014409:Tumor Necrosis Factor-alpha; D054353:Perforin; D015759:Ionomycin; D007371:Interferon-gamma; D053804:Granzymes
references: J Immunol. 2011 Mar 15;186(6):3421-31
references: 21296979
references: J Immunol. 1983 Oct;131(4):1789-96
references: 6225799
references: Cell Immunol. 2010;264(1):97-103
references: 20553755
references: Rom J Morphol Embryol. 2010;51(4):633-40
references: 21103619
references: Clin Exp Immunol. 2005 Jul;141(1):165-73
references: 15958083
references: J Rheumatol. 1996 Jan;23(1):171-7
references: 8838528
references: Arthritis Rheum. 2009 Jun;60(6):1753-63
references: 19479851
references: J Rheumatol. 2002 Feb;29(2):288-91
references: 11838846
references: J Immunol. 2004 Dec 1;173(11):6760-6
references: 15557169
references: J Immunol. 1989 Nov 15;143(10):3183-91
references: 2530273
references: Autoimmun Rev. 2005 Apr;4(4):189-94
references: 15893710
references: Rheumatol Int. 2012 Apr;32(4):863-9
references: 21221593
references: Arthritis Rheum. 2003 Oct;48(10):2888-97
references: 14558095
references: Immunol Today. 1997 Nov;18(11):538-42
references: 9386350
references: Nat Rev Immunol. 2002 Feb;2(2):106-15
references: 11910892
references: Clin Dev Immunol. 2012;2012:934161
references: 22969819
references: Ann N Y Acad Sci. 2009 Sep;1173:310-7
references: 19758167
references: Annu Rev Immunol. 1999;17:189-220
references: 10358757
references: Arthritis Rheum. 1998 Jul;41(7):1241-50
references: 9663482
references: J Biomed Biotechnol. 2010;2010:365083
references: 20467470
references: J Immunol. 1987 Jun 15;138(12):4539-44
references: 3584981
references: Immunology. 2010 Dec;131(4):451-8
references: 21039469
references: J Clin Immunol. 2005 Mar;25(2):99-105
references: 15821886
references: Joint Bone Spine. 2009 Oct;76(5):464-73
references: 19773191
references: Arthritis Rheum. 1992 Jun;35(6):630-40
references: 1599520
references: J Biol Chem. 2003 Jan 3;278(1):289-95
references: 12417585
references: J Clin Pathol. 2003 Jul;56(7):481-90
references: 12835292
references: Adv Immunol. 2000;76:227-324
references: 11079100
references: Lupus. 1997;6(9):708-12
references: 9412985
references: Biomed Pharmacother. 2006 Feb;60(2):92-5
references: 16256301
references: Nat Immunol. 2004 Oct;5(10):996-1002
references: 15454923
references: Arthritis Rheum. 2011 Jun;63(6):1698-706
references: 21370226
references: Best Pract Res Clin Rheumatol. 2005 Oct;19(5):685-708
references: 16150398
references: Trends Immunol. 2001 Nov;22(11):633-40
references: 11698225
references: Ann Rheum Dis. 1990 Sep;49(9):690-3
references: 1700674
references: JAMA. 2011 Aug 10;306(6):668
references: 21828332
references: Arthritis Rheum. 1980 Nov;23(11):1274-81
references: 6969594
references: Scand J Rheumatol. 2004;33(6):409-16
references: 15794201